carbostyril has been researched along with Angiogenesis, Pathologic in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (33.33) | 29.6817 |
| 2010's | 10 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chan, AT; Chan, SL; Hui, CW; Lau, CP; Lui, VW; Ma, BB; Wong, CH; Yeo, W; Zhou, Q | 1 |
| Aparicio, A; Cao, X; Chinnaiyan, AM; Corn, PG; Efstathiou, E; Iyer, MK; Kundra, V; Li Ning Tapia, EM; Logothetis, CJ; McKeehan, W; Navone, NM; Palanisamy, N; Ravoori, MK; Robinson, DR; Starbuck, MW; Tapia, EM; Troncoso, P; Vazquez, ES; Wan, X; Wang, F; Wu, YM; Yang, J; Zurita, AJ | 1 |
| Abdelhamid, IA; Ahmed, AG; Attia, YM; Ghozlan, SA; Mohamed, MF; Shouman, SA | 1 |
| Akiel, MA; Biagi, JM; Christadore, LM; Fisher, PB; Gredler, R; Hansen, U; Jariwala, N; Rajasekaran, D; Robertson, CL; Sarkar, D; Schaus, SE; Shen, XN; Siddiq, A; Subler, MA; Willoughby, JL; Windle, JJ; Yunes, SA | 1 |
| Desco, M; Hernández-Agudo, E; Hidalgo, M; Lopez-Casas, PP; Megías, D; Mondejar, T; Mouron, S; Mulero, F; Quintela-Fandino, M; Sanchez, J; Soto-Montenegro, ML | 1 |
| Mabeta, P | 1 |
| Auer, R; Mabeta, P; Mphahlele, MJ | 1 |
| Bing, C; González-Muniesa, P; Trayhurn, P | 1 |
| Doçi, CL; Hasina, R; Lingen, MW; Mankame, TP; Wroblewski, K; Zhou, G | 1 |
| Becker, RE; Dalrymple, SL; DeWeese, TL; Isaacs, JT; Zhou, H | 1 |
| Chen, ZY; Guo, RP; Guo, ZX; Li, SH; Li, XJ; Peng, LX; Qian, CN; Shi, M; Wei, W; Zhong, C | 1 |
| Bonginelli, P; Capaccetti, B; Fanelli, M; Gasparini, G; Gattuso, D; Longo, R; Sarmiento, R | 1 |
| Cohen-Jonathan, E; Delmas, C; End, D; Favre, G; Rochaix, P; Toulas, C | 1 |
| Aukerman, SL; Garrett, E; Gelb, AB; Harris, A; Heise, C; Lee, SH; Lopes de Menezes, D; Nordahl, L; Samara, E; Vora, J; Ye, H | 1 |
| Björk, A; Dalrymple, SL; Garrison, JB; Isaacs, JT; Kyprianou, N; Leanderson, T; Olsson, A; Pili, R; Qian, DZ | 1 |
1 review(s) available for carbostyril and Angiogenesis, Pathologic
| Article | Year |
|---|---|
[Innovative treatment in oncology].
Topics: Antibodies, Monoclonal; Humans; Neoplasms; Neovascularization, Pathologic; Protein-Tyrosine Kinases; Quinolones | 2002 |
14 other study(ies) available for carbostyril and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Preclinical evaluation of combined TKI-258 and RAD001 in hepatocellular carcinoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzimidazoles; Blotting, Western; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Cell Survival; Everolimus; Humans; Liver Neoplasms; Mice; Mice, Nude; Neovascularization, Pathologic; Proto-Oncogene Proteins c-akt; Quinolones; Sirolimus; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays | 2013 |
Prostate cancer cell-stromal cell crosstalk via FGFR1 mediates antitumor activity of dovitinib in bone metastases.
Topics: Animals; Antineoplastic Agents; Apoptosis; Benzimidazoles; Bone and Bones; Bone Neoplasms; Cell Line, Tumor; Disease Models, Animal; Fibroblast Growth Factor 2; Gene Expression Regulation, Neoplastic; Humans; Male; Mice; Neovascularization, Pathologic; Osteoblasts; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Quinolones; Receptor, Fibroblast Growth Factor, Type 1; Signal Transduction; Stromal Cells; Tumor Microenvironment; Xenograft Model Antitumor Assays | 2014 |
Cytotoxic and antimicrobial evaluations of novel apoptotic and anti-angiogenic spiro cyclic 2-oxindole derivatives of 2-amino-tetrahydroquinolin-5-one.
Topics: Angiogenesis Inhibitors; Anti-Bacterial Agents; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Caspase 9; Cell Proliferation; Disk Diffusion Antimicrobial Tests; DNA Fragmentation; Dose-Response Relationship, Drug; Drug Design; Hep G2 Cells; Humans; Indoles; MCF-7 Cells; Molecular Structure; Neovascularization, Pathologic; Oxindoles; Quinolones; Signal Transduction; Structure-Activity Relationship; Tumor Suppressor Protein p53; Vascular Endothelial Growth Factor A | 2015 |
Small molecule inhibitors of Late SV40 Factor (LSF) abrogate hepatocellular carcinoma (HCC): Evaluation using an endogenous HCC model.
Topics: Animals; Antineoplastic Agents; Apoptosis; Benzodioxoles; Carcinoma, Hepatocellular; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Diethylnitrosamine; DNA-Binding Proteins; Dose-Response Relationship, Drug; Genes, myc; Genetic Predisposition to Disease; Humans; Liver Neoplasms, Experimental; Mice, Transgenic; Mitosis; Molecular Targeted Therapy; Neovascularization, Pathologic; Phenotype; Quinolones; Signal Transduction; Time Factors; Transcription Factors | 2015 |
Monitoring vascular normalization induced by antiangiogenic treatment with (18)F-fluoromisonidazole-PET.
Topics: Angiogenesis Inhibitors; Animals; Antimetabolites, Antineoplastic; Benzimidazoles; Breast; Breast Neoplasms; Cell Hypoxia; Cell Line, Tumor; Deoxycytidine; Female; Fluorine Radioisotopes; Gemcitabine; Humans; Mice; Mice, Nude; Misonidazole; Neovascularization, Pathologic; Pancreas; Pancreatic Neoplasms; Positron-Emission Tomography; Quinolones | 2016 |
PF573,228 inhibits vascular tumor cell growth, migration as well as angiogenesis, induces apoptosis and abrogates PRAS40 and S6RP phosphorylation.
Topics: Animals; Antineoplastic Agents; Aorta; Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Enzyme Inhibitors; Focal Adhesion Protein-Tyrosine Kinases; Hemangioendothelioma; Male; Mice; Neoplasm Proteins; Neovascularization, Pathologic; Phosphoproteins; Phosphorylation; Protein Processing, Post-Translational; Quinolones; Rats, Sprague-Dawley; Ribosomal Protein S6; Sulfones; Tissue Culture Techniques | 2016 |
Evaluation of the antiangiogenic effects of 2-aryl-3-bromoquinolin-4(1H)-ones and a NCH3-4-oxo derivative.
Topics: Angiogenesis Inhibitors; Animals; Aorta; Cell Proliferation; Endothelial Cells; Humans; In Vitro Techniques; Male; Microvessels; Molecular Structure; Neovascularization, Pathologic; Quinolones; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship | 2009 |
Upregulation of the expression of inflammatory and angiogenic markers in human adipocytes by a synthetic cannabinoid, JTE-907.
Topics: Adipocytes; Biomarkers; Cannabinoid Receptor Antagonists; Cannabinoids; Cell Differentiation; Chemokine CCL2; Dioxoles; Female; Humans; Inflammation; Inflammation Mediators; Interleukin-1beta; Middle Aged; Neovascularization, Pathologic; Quinolones; Receptors, Cannabinoid; TRPV Cation Channels; Up-Regulation | 2010 |
Dual inhibition of vascular endothelial growth factor receptor and epidermal growth factor receptor is an effective chemopreventive strategy in the mouse 4-NQO model of oral carcinogenesis.
Topics: 4-Nitroquinoline-1-oxide; Animals; Antineoplastic Agents; Carcinogens; Disease Models, Animal; Drug Resistance, Neoplasm; Epithelial-Mesenchymal Transition; ErbB Receptors; Immunohistochemistry; Mice; Mice, Inbred CBA; Mouth Neoplasms; Neovascularization, Pathologic; Piperidines; Quinazolines; Quinolones; Receptors, Vascular Endothelial Growth Factor | 2010 |
Tasquinimod prevents the angiogenic rebound induced by fractionated radiation resulting in an enhanced therapeutic response of prostate cancer xenografts.
Topics: Angiogenesis Inhibitors; Animals; Combined Modality Therapy; Humans; Male; Mice; Mice, Nude; Neovascularization, Pathologic; Prostatic Neoplasms; Quinolines; Quinolones; Radiation-Sensitizing Agents; Transplantation, Heterologous; Tumor Cells, Cultured | 2012 |
Dovitinib preferentially targets endothelial cells rather than cancer cells for the inhibition of hepatocellular carcinoma growth and metastasis.
Topics: Animals; Apoptosis; Benzimidazoles; Biomarkers, Tumor; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Cell Proliferation; Endothelial Cells; Humans; Liver Neoplasms; Male; Mice; Neoplasm Invasiveness; Neoplasm Metastasis; Neovascularization, Pathologic; Protein Kinase Inhibitors; Quinolones; Receptor Protein-Tyrosine Kinases; Signal Transduction; Xenograft Model Antitumor Assays | 2012 |
The farnesyltransferase inhibitor R115777 reduces hypoxia and matrix metalloproteinase 2 expression in human glioma xenograft.
Topics: Alkyl and Aryl Transferases; Animals; Antineoplastic Agents; Cell Hypoxia; Enzyme Inhibitors; Farnesyltranstransferase; Glioblastoma; Glioma; Humans; Immunoenzyme Techniques; Matrix Metalloproteinase 2; Mice; Mice, Nude; Neovascularization, Pathologic; Oxygen; Quinolones; Transplantation, Heterologous; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2003 |
In vivo target modulation and biological activity of CHIR-258, a multitargeted growth factor receptor kinase inhibitor, in colon cancer models.
Topics: Animals; Benzimidazoles; Biomarkers, Tumor; Cell Proliferation; Colonic Neoplasms; Female; Growth Substances; Humans; Mice; Neovascularization, Pathologic; Phosphorylation; Proto-Oncogene Proteins c-sis; Quinolones; Transplantation, Heterologous; Vascular Endothelial Growth Factor Receptor-1 | 2005 |
Identification of ABR-215050 as lead second generation quinoline-3-carboxamide anti-angiogenic agent for the treatment of prostate cancer.
Topics: Angiogenesis Inhibitors; Animals; Cell Growth Processes; Cell Line, Tumor; Dogs; Humans; Hydroxyquinolines; Male; Mice; Neovascularization, Pathologic; Prostatic Neoplasms; Quinolines; Quinolones; Rats; Xenograft Model Antitumor Assays | 2006 |